# Agent Era — Final Checkpoint & Closure (2026-08-28)

**Read this first if you are a fresh session and see any reference to the "Tawveeri Agent Era"
research program, the 30-task validation subset, Condition A/B/C, or Payload v1.0/v1.1. This
document is the terminal state of that program. Do not resume it without a fresh founder decision
— see §4.**

---

## 1. Formal verdict

> **FUNDAMENTAL VALUE GAP VERDICT UNDER THE PRE-COMMITTED C2 KILL CRITERION FOR THE TESTED BROAD
> AGENT-LAYER HYPOTHESIS.**

Precise statement of what failed, so this is not over-read in either direction:

**The tested hypothesis** — *that adding Tawveeri's verification-first commercial payload to a
general open-web shopping agent produces material, attributable improvement over open-web search
alone* — **FAILED to demonstrate value under the frozen experiment.**

This verdict is scoped to that specific hypothesis, tested under that specific experimental design
(`EXECUTION_PROTOCOL_v1.0.md`, `CONDITION_C_PAYLOAD_v1.1.md`, `C2_EXPERIMENT_FREEZE.md`, the frozen
30-task subset). It is **not** a general claim about Tawveeri's value. See §3 for the explicit
boundary of what is and is not established.

---

## 2. Measured result (frozen, not to be revised)

| Metric | Value |
|---|---|
| A2 (open web only) mean score | **93.84%** |
| C2 (open web + Payload v1.1 + agent-use contract) mean score | **80.03%** |
| C2 − A2 | **−13.81 percentage points** |
| Degradation rate (tasks scored ≤−5pp) | **63.3% (19/30)** |
| Improved tasks | 3/30 (LAP-001, APP-001, CAM-003) |
| Tasks with a unique, attributable Tawveeri-caused improvement | **0** |
| Targeted v1.0 over-trust failure mechanism (accept-without-verification harm) | improved materially, **~25% → 8–12%** of engaged tasks |
| Kill-criterion thresholds cleared (of 4 real numeric thresholds) | **at most 1, and only under the most generous reading** |

**Full detail, per-task table, and the three newly-discovered failure modes**: see
`docs/benchmark/C2_RESULTS_REPORT_2026-08-28.md`. That report and this checkpoint are consistent;
this document is the durable, cross-session summary — the benchmark report is the underlying
evidence record.

**The three raw-Improved cases were driven by the agent's own independent verification, not by
trusting Tawveeri's data, and all three were independently reproducible by A2 (open web alone) in
this same run** — including the CAM-003 anti-fabrication case that was the clearest win in the
prior (v1.0) run. That means zero improvements in this run can be causally attributed to Tawveeri's
payload specifically.

**Methodological nuance, recorded precisely because it matters for how this verdict should be read
in the future**: not every C2 degradation is causally attributable to incorrect Tawveeri data. Some
of the measured harm (most notably APP-006, the single most severe degradation) was an ordinary
independent-research error unrelated to the payload at all — A2 did not make the same mistake, but
the mistake was not caused by trusting Tawveeri either. The correct strategic reading of this
experiment is therefore **failure to demonstrate net agent-layer value**, not **proof that Tawveeri
data is intrinsically harmful**. Both the aggregate negative result and this attribution nuance are
true simultaneously, and neither should be dropped when this is summarized in the future.

**The diagnosis-to-redesign reasoning chain itself worked, on the one mechanism it targeted**: the
harm diagnosis (`CAUSAL_HARM_DIAGNOSIS_2026-08-28.md`) correctly identified "accepting flagged-
uncertain payload data without verification" as the dominant harm pattern in v1.0 (57% of harm
cases), and the resulting redesign (`CONDITION_C_PAYLOAD_v1.1.md`) measurably reduced exactly that
pattern (~25% → 8–12% of engaged tasks). That the aggregate result still failed shows the targeted
mechanism was real but not the dominant driver of *overall* answer quality — other failure modes
(data volatility outrunning "current" freshness windows, verification performed but not acted on,
ordinary research-quality variance, and per-leg logging blind spots) dominate instead, and none of
those is solved by further payload-schema iteration.

---

## 3. What this experiment did and did not establish

### Established:

- Open-web agents are already very strong on this shopping task set (A2's own mean, 93.84%, is
  high in absolute terms — the baseline this experiment measured against is a strong one, not a
  weak strawman).
- Tawveeri's current agent-facing information, even after a full verification-first redesign built
  from a rigorous causal diagnosis, did not create measurable incremental value above that
  open-web baseline.
- Anti-fabrication / uncertainty signaling (the `not_tracked`/`coverage_status` discipline) can help
  in specific cases, but was not unique enough or consistent enough across this run to establish a
  broad agent-layer business case — the clearest such case (CAM-003) was independently replicated
  by open-web research alone.
- More information handed to an agent is not automatically better information — the richer,
  better-structured v1.1 payload produced a *worse* aggregate result than the flawed v1.0 payload.
- Verification semantics alone (explicit confidence tiers, mandatory-verification triggers, an
  agent-use contract) are insufficient to establish strategic value — they closed one real failure
  mode without improving the outcome that mattered.

### NOT established:

- That Tawveeri has no consumer value.
- That Tawveeri cannot become a successful shopping product.
- That no future agent-related opportunity could ever exist.
- That every C2 error was caused by Tawveeri (several were independent agent/web-research mistakes
  or execution variance — see §2's methodological nuance).
- That consumer-facing distribution/growth has been validated (this experiment did not test that
  question at all — it is a separate program; see §4).

---

## 4. Program status — do not resume automatically

```
AGENT ERA BROAD PAYLOAD HYPOTHESIS: CLOSED / STOPPED under the C2 kill criterion (2026-08-28).
```

Per the kill criterion in `C2_EXPERIMENT_FREEZE.md` §7, verbatim: *"Do not redesign repeatedly
until the benchmark passes."* Accordingly, as of this checkpoint:

- **No Payload v1.2** (or any further payload-semantics redesign) is proposed, drafted, or queued.
- **No new agent-use contract iteration** is proposed.
- **No MCP server or Agent API** is proposed or has been built.
- **No expansion to the remaining 70 (or 100) benchmark tasks** is authorized or queued.
- **Do not continue this branch automatically in a future session** — a fresh session picking up
  this codebase should read this checkpoint, understand the program is closed, and NOT re-open,
  re-run, or iterate on any part of it (Condition A/B/C, Payload v1.0/v1.1, the 30-task subset,
  `EXECUTION_PROTOCOL_v1.0.md`, `C2_EXPERIMENT_FREEZE.md`) without a **new, explicit founder
  decision, grounded in materially new evidence** — not a continuation of this experiment's own
  logic, and not "one more design iteration to see if it passes this time."

### Frozen artifacts, for reference only (do not re-run or re-freeze)

- `docs/AGENT_ERA_PHASE0_RESEARCH_2026-08-27.md` — original strategic/landscape research.
- `docs/benchmark/tawveeri-agent-benchmark-v1.0.json`, `RUBRIC_v1.0.md`, `EXECUTION_PROTOCOL_v1.0.md`
  — frozen benchmark instruments.
- `docs/benchmark/validation-subset-v1.0.json` / `validation-subset-task-text-v1.0.json` — the
  frozen 30-task subset.
- `docs/benchmark/CAUSAL_VALIDATION_REPORT_30TASK_2026-08-28.md` — the original v1.0 causal run.
- `docs/benchmark/CAUSAL_HARM_DIAGNOSIS_2026-08-28.md` — the harm diagnosis that drove the redesign.
- `docs/benchmark/CONDITION_C_PAYLOAD_v1.1.md`, `C2_EXPERIMENT_FREEZE.md` — the frozen v1.1 design
  and its pre-committed C2 test.
- `docs/benchmark/condition-c-payload-data-v1.0.json`, `condition-c-payload-data-v1.1.json` — the
  two payload data snapshots actually used (both are point-in-time; both are stale by the time any
  future session reads them — do not reuse without rebuilding from fresh production data, and do
  not do that rebuild without a fresh founder decision per this section).
- `docs/benchmark/C2_RESULTS_REPORT_2026-08-28.md` — the full C2 result and per-task detail.
- This document — the durable closure checkpoint.

### Likely next strategic program (not started, not authorized here)

The founder has indicated the likely next strategic program is **consumer-facing Distribution &
Growth** — but this requires its own separate founder start decision and its own measurable
hypotheses. **Nothing in this closure authorizes starting that program.** A future session should
not infer authorization to begin Distribution/Growth work from the mere fact that the Agent Era
program is closed.

---

## 5. Separate, unrelated item logged here for cross-reference only

A live production defect (AirPods Pro 2 SAR-79 price recurrence) was discovered incidentally during
the C2 read-only data-gathering pass. That is production engineering work, not benchmark work, and
was tracked entirely separately across two incident documents, both now **CLOSED and verified in
production**:

- `docs/P0_AIRPODS_PRO2_RECURRENCE_2026-08-28.md` — `tps_product_projection` /
  `build-tps-projection.ts` freshness fix + `tawveeri_tps_products` Algolia sync pagination fix.
- `docs/P0_LIVE_SEARCH_STALE_PRICE_2026-08-28.md` — the live `searchTPSCanonical()` fix (the
  actual shopper-facing serving path), including a second defect found during its own live
  verification (a tie-breaking bug that neutralized the first fix) and its resolution, final commit
  `c8e44da`.

Final verified state: `tawveeri.com` search now returns **SAR 1,049** for AirPods Pro 2 (was SAR
79), and the same fix corrects the other checked cases from the 629-pair / 626-canonical blast
radius identified during the incident. Do not reopen either incident document without fresh
production evidence — this closure does not authorize re-litigating them from memory.

Decision Register: **ADR-272** (`docs/DECISIONS.md`) records the Agent Era program's own closure
decision; the P0 incident is production engineering, not a benchmark decision, and has no separate
ADR — its two incident documents above are its decision record.
